Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn(2+) and Mg (2+).

Fernández JM, Molinuevo MS, McCarthy AD, Cortizo AM.

Biometals. 2014 Jun;27(3):601-7. doi: 10.1007/s10534-014-9733-8. Epub 2014 Apr 16.

PMID:
24737106
2.

Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.

Felice JI, Gangoiti MV, Molinuevo MS, McCarthy AD, Cortizo AM.

Metabolism. 2014 Feb;63(2):296-305. doi: 10.1016/j.metabol.2013.11.002. Epub 2013 Nov 7.

PMID:
24355623
3.

Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin.

Tolosa MJ, Chuguransky SR, Sedlinsky C, Schurman L, McCarthy AD, Molinuevo MS, Cortizo AM.

Diabetes Res Clin Pract. 2013 Aug;101(2):177-86. doi: 10.1016/j.diabres.2013.05.016. Epub 2013 Jun 24.

PMID:
23806481
4.

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.

Fernández JM, Molinuevo MS, Sedlinsky C, Schurman L, Cortizo AM, McCarthy AD.

Eur J Pharmacol. 2013 Apr 15;706(1-3):41-7. doi: 10.1016/j.ejphar.2013.02.042. Epub 2013 Mar 13.

PMID:
23499695
5.

Morphological changes induced by advanced glycation endproducts in osteoblastic cells: effects of co-incubation with alendronate.

Gangoiti MV, Anbinder PS, Cortizo AM, McCarthy AD.

Acta Histochem. 2013 Sep;115(7):649-57. doi: 10.1016/j.acthis.2013.01.004. Epub 2013 Mar 5.

PMID:
23465485
6.

Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: evaluation of cytotoxicity and early bacterial adhesion.

Cortizo MC, Oberti TG, Cortizo MS, Cortizo AM, Fernández Lorenzo de Mele MA.

J Dent. 2012 Apr;40(4):329-37. doi: 10.1016/j.jdent.2012.01.008. Epub 2012 Jan 25.

PMID:
22305778
7.

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

Sedlinsky C, Molinuevo MS, Cortizo AM, Tolosa MJ, Felice JI, Sbaraglini ML, Schurman L, McCarthy AD.

Eur J Pharmacol. 2011 Oct 15;668(3):477-85. doi: 10.1016/j.ejphar.2011.07.033. Epub 2011 Aug 5.

PMID:
21839072
8.

Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo MS, Cortizo AM.

J Tissue Eng Regen Med. 2011 Jun;5(6):e126-35. doi: 10.1002/term.394. Epub 2011 Feb 10.

PMID:
21312338
9.

Characterization of poly(epsilon-caprolactone)/polyfumarate blends as scaffolds for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo AM, McCarthy AD, Cortizo MS.

J Biomater Sci Polym Ed. 2010;21(10):1297-312. doi: 10.1163/092050609X12517190417632. Epub 2010 Jun 8.

PMID:
20534186
10.

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C.

J Bone Miner Res. 2010 Feb;25(2):211-21. doi: 10.1359/jbmr.090732.

PMID:
19594306
11.

Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.

Gangoiti MV, Cortizo AM, Arnol V, Felice JI, McCarthy AD.

Eur J Pharmacol. 2008 Dec 14;600(1-3):140-7. doi: 10.1016/j.ejphar.2008.10.031. Epub 2008 Oct 21.

PMID:
18973752
12.

Biocompatibility and biodegradation of polyester and polyfumarate based-scaffolds for bone tissue engineering.

Cortizo MS, Molinuevo MS, Cortizo AM.

J Tissue Eng Regen Med. 2008 Jan;2(1):33-42. doi: 10.1002/term.62.

PMID:
18273918
13.

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.

Schurman L, McCarthy AD, Sedlinsky C, Gangoiti MV, Arnol V, Bruzzone L, Cortizo AM.

Exp Clin Endocrinol Diabetes. 2008 Jun;116(6):333-40. doi: 10.1055/s-2007-992786.

PMID:
18273753
14.

Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells.

Mercer N, Ahmed H, Etcheverry SB, Vasta GR, Cortizo AM.

Mol Cell Biochem. 2007 Dec;306(1-2):87-94. Epub 2007 Jul 28.

PMID:
17660952
15.

Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells.

Molinuevo MS, Cortizo AM, Etcheverry SB.

Cancer Chemother Pharmacol. 2008 Apr;61(5):767-73. Epub 2007 Jun 19.

PMID:
17576559
16.

Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells.

Molinuevo MS, Bruzzone L, Cortizo AM.

Eur J Pharmacol. 2007 May 7;562(1-2):28-33. Epub 2007 Feb 8.

PMID:
17341419
17.

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.

Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L.

Eur J Pharmacol. 2006 Apr 24;536(1-2):38-46. Epub 2006 Feb 28.

PMID:
16564524
18.

Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action.

Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L.

Int J Biochem Cell Biol. 2006;38(7):1171-80. Epub 2006 Jan 9.

PMID:
16455285
19.

Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.

Vaisman DN, McCarthy AD, Cortizo AM.

Biol Trace Elem Res. 2005 May;104(2):131-40.

PMID:
15894813
20.

Macrophage activation by a vanadyl-aspirin complex is dependent on L-type calcium channel and the generation of nitric oxide.

Molinuevo MS, Etcheverry SB, Cortizo AM.

Toxicology. 2005 Jun 1;210(2-3):205-12.

PMID:
15840434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk